Vancomycin Trough Concentration Poorly Characterizes AUC: Is It Time to Transition to AUC-Based Vancomycin Monitoring?

Abstract

Get full access to this article

View all access options for this article.

References

Men

Zhai

et al . Association between the AUC_0-24/MIC ratio of vancomycin and its clinical effectiveness: a systematic review and meta-analysis. PLoS One. 2016;11:e0146224.

Rybak

Lomaestro

Rotschafer

et al . Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;62:82.

Hale

Seabury

Steele

et al . Are vancomycin trough concentrations of 15 to 20 mg/L associated with increased attainment of an AUC/MIC ≥ 400 in patients with presumed MRSA infection? J Pharm Pract. 2017;30:329-335.

Pai

Neely

Rodvold

et al . Innovative approaches to optimizing the delivery of vancomycin in individual patients. Adv Drug Deliv Rev. 2014;77:50.

Suzuki

Kawasaki

Sato

et al . Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant Staphylococcus aureus pneumonia. Chemotherapy. 2012;58:308.